BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leung C, Wadsworth SJ, Yang SJ, Dorscheid DR. Structural and functional variations in human bronchial epithelial cells cultured in air-liquid interface using different growth media. Am J Physiol Lung Cell Mol Physiol 2020;318:L1063-73. [PMID: 32208929 DOI: 10.1152/ajplung.00190.2019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Bartman CM, Stelzig KE, Linden DR, Prakash YS, Chiarella SE. Passive siRNA transfection method for gene knockdown in air-liquid interface airway epithelial cell cultures. Am J Physiol Lung Cell Mol Physiol 2021;321:L280-6. [PMID: 34037474 DOI: 10.1152/ajplung.00122.2021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Karaguzel D, Sarac BE, Akel Bilgic H, Summak GY, Unal MA, Kalayci O, Karaaslan C. House dust mite-derived allergens effect on matrix metalloproteases in airway epithelial cells. Exp Lung Res 2021;47:436-50. [PMID: 34739337 DOI: 10.1080/01902148.2021.1998734] [Reference Citation Analysis]
3 Rajan A, Weaver AM, Aloisio GM, Jelinski J, Johnson HL, Venable SF, McBride T, Aideyan L, Piedra FA, Ye X, Melicoff-Portillo E, Yerramilli MRK, Zeng XL, Mancini MA, Stossi F, Maresso AW, Kotkar SA, Estes MK, Blutt S, Avadhanula V, Piedra PA. The human nose organoid respiratory virus model: an ex-vivo human challenge model to study RSV and SARS-CoV-2 pathogenesis and evaluate therapeutics. bioRxiv 2021:2021. [PMID: 34341793 DOI: 10.1101/2021.07.28.453844] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Woodall MNJ, Masonou T, Case KM, Smith CM. Human models for COVID-19 research. J Physiol 2021. [PMID: 34287894 DOI: 10.1113/JP281499] [Reference Citation Analysis]
5 Callaghan PJ, Ferrick B, Rybakovsky E, Thomas S, Mullin JM. Epithelial barrier function properties of the 16HBE14o- human bronchial epithelial cell culture model. Biosci Rep 2020;40:BSR20201532. [PMID: 32985670 DOI: 10.1042/BSR20201532] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
6 Kryvenko V, Vadász I. Novel transfection methods in primary lung cell cultures. Am J Physiol Lung Cell Mol Physiol 2021;321:L734-5. [PMID: 34549594 DOI: 10.1152/ajplung.00371.2021] [Reference Citation Analysis]
7 Aydin M, Naumova EA, Bellm A, Behrendt AK, Giachero F, Bahlmann N, Zhang W, Wirth S, Paulsen F, Arnold WH, Ehrhardt A. From Submerged Cultures to 3D Cell Culture Models: Evolution of Nasal Epithelial Cells in Asthma Research and Virus Infection. Viruses 2021;13:387. [PMID: 33670992 DOI: 10.3390/v13030387] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Chhetri BK, Tedbury PR, Sweeney-Jones AM, Mani L, Soapi K, Manfredi C, Sorscher E, Sarafianos SG, Kubanek J. Marine Natural Products as Leads against SARS-CoV-2 Infection. J Nat Prod 2022;85:657-65. [PMID: 35290044 DOI: 10.1021/acs.jnatprod.2c00015] [Reference Citation Analysis]
9 Chen JS, Alfajaro MM, Chow RD, Wei J, Filler RB, Eisenbarth SC, Wilen CB. Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection. J Virol 2021:JVI. [PMID: 33441348 DOI: 10.1128/JVI.00014-21] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 14.0] [Reference Citation Analysis]
10 Liu J, Yao X, Wang Z, Ye J, Luan C, He Y, Lin H, Fu J. A flexible porous chiral auxetic tracheal stent with ciliated epithelium. Acta Biomater 2021;124:153-65. [PMID: 33529770 DOI: 10.1016/j.actbio.2021.01.044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Rahman M, Ravichandran R, Bansal S, Sanborn K, Bowen S, Eschbacher J, Sureshbabu A, Fleming T, Bharat A, Walia R, Hachem R, Bremner RM, Smith MA, Mohanakumar T. Novel role for tumor suppressor gene, liver kinase B1, in epithelial-mesenchymal transition leading to chronic lung allograft dysfunction. Am J Transplant 2021. [PMID: 34859569 DOI: 10.1111/ajt.16903] [Reference Citation Analysis]
12 Tu WJ, McCuaig RD, Melino M, Rawle DJ, Le TT, Yan K, Suhrbier A, Johnston RL, Koufariotis LT, Waddell N, Cross EM, Tsimbalyuk S, Bain A, Ahern E, Collinson N, Phipps S, Forwood JK, Seddiki N, Rao S. Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication. Cell Discov 2021;7:37. [PMID: 34031383 DOI: 10.1038/s41421-021-00279-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Chen JS, Alfajaro MM, Wei J, Chow RD, Filler RB, Eisenbarth SC, Wilen CB. Cyclooxgenase-2 is induced by SARS-CoV-2 infection but does not affect viral entry or replication. bioRxiv 2020:2020. [PMID: 32995789 DOI: 10.1101/2020.09.24.312769] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
14 Lee DF, Lethem MI, Lansley AB. A comparison of three mucus-secreting airway cell lines (Calu-3, SPOC1 and UNCN3T) for use as biopharmaceutical models of the nose and lung. Eur J Pharm Biopharm 2021;167:159-74. [PMID: 34332033 DOI: 10.1016/j.ejpb.2021.07.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Yaqub N, Wayne G, Birchall M, Song W. Recent advances in human respiratory epithelium models for drug discovery. Biotechnol Adv 2021;:107832. [PMID: 34481894 DOI: 10.1016/j.biotechadv.2021.107832] [Reference Citation Analysis]
16 Selo MA, Sake JA, Kim KJ, Ehrhardt C. In vitro and ex vivo models in inhalation biopharmaceutical research - advances, challenges and future perspectives. Adv Drug Deliv Rev 2021;:113862. [PMID: 34256080 DOI: 10.1016/j.addr.2021.113862] [Reference Citation Analysis]
17 Rajan A, Weaver AM, Aloisio GM, Jelinski J, Johnson HL, Venable SF, McBride T, Aideyan L, Piedra FA, Ye X, Melicoff-Portillo E, Yerramilli MRK, Zeng XL, Mancini MA, Stossi F, Maresso AW, Kotkar SA, Estes MK, Blutt S, Avadhanula V, Piedra PA. The Human Nose Organoid Respiratory Virus Model: an Ex Vivo Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics. mBio 2022;:e0351121. [PMID: 35164569 DOI: 10.1128/mbio.03511-21] [Reference Citation Analysis]
18 Wiese-Rischke C, Murkar RS, Walles H. Biological Models of the Lower Human Airways-Challenges and Special Requirements of Human 3D Barrier Models for Biomedical Research. Pharmaceutics 2021;13:2115. [PMID: 34959396 DOI: 10.3390/pharmaceutics13122115] [Reference Citation Analysis]